156 results
8-K
KA
Kineta Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:00pm
available options to regain compliance with the bid price requirement.
There can be no assurance that the Company will be able to regain compliance
8-K
KA
Kineta Inc
12 Mar 24
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts
8:05am
and there can be no assurance that such activities will result in any agreements or transactions that will enhance stockholder value. Evaluating … that require stockholder approval may not be approved by Kineta’s stockholders.
There can be no assurance that Kineta’s process to identify and evaluate
8-K
EX-99.1
8k25yo7u
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
424B3
qbkb6uuik6b3 qnhad
13 Nov 23
Prospectus supplement
5:28pm
8-K
EX-10.1
nv1fi
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
424B5
7pciod25hrod g59c12
5 Oct 23
Prospectus supplement for primary offering
10:47am
8-K
uykpe
3 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:31am
424B3
ykiz bgu7zvf
12 Jun 23
Prospectus supplement
5:01pm